DOCSLIB.ORG

Facultad De Ciencias De La Actividad Física Y Del Deporte - Inef

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Facultad De Ciencias De La Actividad Física Y Del Deporte - Inef UNIVERSIDAD POLITÉCNICA DE MADRID FACULTAD DE CIENCIAS DE LA ACTIVIDAD FÍSICA Y DEL DEPORTE - INEF Evolution and treatment of vitamin B12 deficiency as a risk factor for (cognitive and functional) neurodegenerative diseases in institutionalized elderly Evolución y tratamiento de la deficiencia de vitamina B12 como factor de riesgo de enfermedades neurodegenerativas (cognitivas y funcionales) en las personas mayores institucionalizadas TESIS DOCTORAL ULRIKE ALBERS Licenciada en Ciencia y Tecnología de los Alimentos 2012 DEPARTAMENTO DE SALUD Y RENDIMIENTO HUMANO FACULTAD DE CIENCIAS DE LA ACTIVIDAD FÍSICA Y DEL DEPORTE - INEF Evolution and treatment of vitamin B12 deficiency as a risk factor for (cognitive and functional) neurodegenerative diseases in institutionalized elderly Evolución y tratamiento de la deficiencia de vitamina B12 como factor de riesgo de enfermedades neurodegenerativas (cognitivas y funcionales) en las personas mayores institucionalizadas Ulrike Albers Licenciada en Ciencia y Tecnología de los Alimentos Directores: María Marcela González Gross, Doctora en Farmacia, Profesora Titular de la Universidad Politécnica de Madrid Agustín Meléndez Ortega, Doctor en Ciencias de la Actividad Física y del Deporte, Profesor “Ad honorem” de la Universidad Politécnica de Madrid Madrid, 2012 Photo: Foto Krummen, Lingen Ulrike Albers, 2012 Edita: Universidad Politécnica, Av. Ramiro Maeztu 7, 28040 Madrid Imprime: MuzArt, Impresión Digital; c/ Gaztambide, 56; 28015 Madrid ISBN-10: 84-96398-59-5 ISBN-13: 978-84-96398-59-7 Tribunal nombrado por el Magfco. y Excmo. Sr. Rector de la Universidad Politécnica de Madrid, el día 20 de junio de 2012. PRESIDENTE: D. Luis A. Moreno Aznar, PhD VOCAL: Dña Mary Ward, PhD VOCAL: Dña Ángeles Carbajal Azcona, PhD VOCAL: Dña Christina Breidenassel, PhD SECRETARIA: Dña Ma del Carmen González Chamorro, PhD Realizado el acto de defensa y lectura de la Tesis el día 20 de junio de 2012 en Madrid. Calificación: EL PRESIDENTE LOS VOCALES LA SECRETARIA On ne reçoit pas la sagesse, il faut la découvrir soi-même après un trajet que personne ne peut faire pour nous, ne peut nous épargner, car elle est un point de vue sur les choses. A la recherche du temps perdu, Marcel Proust A Pilar Carazo Salmerón This PhD Thesis has been possible thanks to the following grants and funding: Project I Project title Vitamin B12 deficiency as a risk factor for neurodegenerative diseases. Longitudi- nal study for the evaluation of changes in the vitamin B12 status in Spanish elderly. (P061100509); funded by Axis-Shield Diagnostics Ltd. and Abbott Diagnostics. S.A. Project II Project title Vitamin B12 deficiency as a risk factor for neurodegenerative diseases. Effect of a cobalamin supplement during one month. (P051100649); supported by Whitehall Much GmbH and Abbott Diagnostics. S.A. Ulrike Albers has been financially supported by the University Politécnica de Madrid with a predoctoral scholarship (2008-2011). Grants from the Universidad Politécnica de Madrid to do internships in the following institutions. • Instituto de Medicina Molecular, Lisbon, Portugal. 20th of September-20th De- cember 2009. • Centre d’Investigations Cliniques CHU-Inserm, CIC 9301. Lille, France. 2nd October-31st of December 2010. • School of Biomedical Sciences, University of Ulster, Coleraine, UK. 18th June- 18th September 2011. PUBLICATONS AND PRESENTATIONS FROM THE THESIS Refereed Conference Proceedings and Abstracts Albers U, Pedrero R, Moran P, Cañada D, Meléndez A, González-Gross M. One year follow-up of biochemical and cobalamin status among Spanish institutionalized el- derly. 11th European Nutrition Conference (FENS). Madrid, Spain. 26-29.10.2011. Ann Nutr Metab 2011, 58(suppl 3): 48. González-Gross M, Pedrero-Chamizo R, Albers U. Interrelación entre la condición física, el estado nutricional vitamínico y el estado cognitivo y su influencia sobre la cal- idad de vida en mayores. 4° Congreso internacional de Actividad Física Deportiva para Mayores. Málaga, Spain. 4-6.03.2011. Proceedings ISBN 978-84-777858980. pp. 71-86. Albers U, Palacios G, Pedrero-Chamizo R, Meléndez A, Pietrzik K, González-Gross M. Plurimedication among Spanish institutionalized elderly, a fact that should be con- sidered when examining their nutritional status. II World Congress of Public Health Nutrition and I Latin American Congress of Community Nutrition. Porto, Portu- gal. 23-25.09.2010. Public Health Nutr 2010, 13(9A): 248. Pedrero-Chamizo R, Albers U, Valtueña J, Casajús JA, Castillo MJ, González -Gross M. Strength training is essential in elderly women. 5th World Conference on Women and Sport. Sydney, Australia. 20-23.05.2010. Abstract Book ISBN 978-0-9806738- 0-7, 2010. Pedrero-Chamizo R, Albers U, Valtueña J, Moreno S, Pietrzik K, Castillo MJ González- Gross M. Relation Between Physical Strength and Cognitive Function in Spanish In- stitutionalized Elderly. 3rd International Congress on Physical Activity and Public Health (ICPAPH). Toronto, Canada. 5-8.05.2010. Pedrero Chamizo R, Albers U, Morencos E, Pastor JC, Meléndez A, Castillo MJ, González–Gross M. Valoración del estado nutricional en mayores institucionalizados a través de diferentes marcadores. II Congreso de la FESNAD. Barcelona. Spain. 3-5.03.2010. Albers U, Pedrero-Chamizo R, Meléndez A, Castillo MJ, Pietrzik K, González-Gross M. How effective can a 500 µg oral supplement of vitamin B12 for just 28 days be for institutionalized elderly? XIXth IAGG World Congress of Gerontology and Geriatrics. Paris, France. 5-9.07.2009 Pedrero-Chamizo R, Albers U, Valtueña J, Cañada D, Jathe R, Meléndez A, Castillo MJ, González-Gross M: Evolución de los niveles de fuerza en población mayor insti- tucionalizada de la Comunidad de Madrid. III Jornadas Nacionales de Medicina del Deporte. Zaragoza, Spain. 29-30.05.2009. Pedrero-Chamizo R, Albers U, Valtueña J, Jiménez-Pavón D, Meléndez A, González- Gross M. Valores de referencia en fuerza de prensión manual en población mayor institucionalizada y de vida independiente. III Congreso Internacional de Actividad Físico Deportiva para Mayores. Málaga, Spain. 12-14.03.2009 Pedrero-Chamizo R, Albers U, Piera M, Jiménez-Pavón D, Meléndez A, Castillo MJ, González-Gross M. Gender, age and cognitive score effects on strength in Spanish institutionalized elderly. 13th Annual Congress of the European College of Sport Sciences. Estoril, Portugal. 9-12.07.2008 Pedrero-Chamizo R, Albers U, Valtueña J, Pietrzik K, Meléndez A, Castillo MJ, González-Gross M. Vitamin B12 deficiency. Effects on physical strength and cog- nitive health in Spanish institutionalized elderly. 6th international Conference on Nutrition and Fitness. Athens, Greece. 15-17.05.2008 Albers, U, Pedrero R, Díaz V, Tobaruela JL, Pietrzik K, Castillo MJ, Meléndez A, González-Gross M. Gender differences in vitamin B12 status and functional fitness parameters in Spanish institutionalized elderly. The 6th World Congress on The Aging Male. Tampa, Florida, United States, 21-24.02.2008. Pedrero R, Albers U, Jiménez-Pavón D, Cupeiro R, Meléndez A, Castillo MJ, Gutiér- rez A, González-Gross M. Valoración funcional en personas mayores institucional- izadas. XII Congreso Nacional de la Federación Española de Medicina del De- porte. Sevilla, Spain. 24-27.10.2007. Albers U, Meléndez A, Pietrzik K, Tobaruela JL, Castillo MJ, González-Gross M. Effectiveness of oral Vitamin B12 supplementation in Spanish institutionalized elderly. 7th International Conference VITAMINS - Nutrition and Diagnostics. Prague, Czech Republic. 19-21.09.2007. Albers U, Díaz V, Peinado A, Alvarez M, Sola R, Pietrzik K, Caballero J, Meléndez A, Castillo MJ, González-Gross M. Physical strength and Vitamin B12 in relation to cognitive score in Spanish institutionalized elderly. 10th European Nutrition Con- ference Paris, France. 10-13.07.2007. Ann Nutr Metab 2007; 51 (suppl 1): 119-120. Refereed Journal Publications Albers U, Palacios G, Pedrero-Chamizo R, Meléndez A, Pietrzik K, González-Gross M. La polimedicación en mayores institucionalizados. Su efecto sobre los niveles de vitamina B12, folato y homocisteína. Nutr Hosp. 2012;27(1): 296-300. Albers U, Pedrero R, Meléndez A, Pietrzik K, Castillo MJ, González-Gross M. Ef- fectiveness of a 28 days oral cyanocobalamin supplementation on vitamin B status in Spanish institutionalized elderly. (accepted in Int J Vitam Nutr Res) Contents Contents I List of Tables V List of Figures VII Nomenclature IX Glossary XI Abstract of the Thesis XIII Resumen de la Tesis XVII 1 INTRODUCTION 1 1.1 Introduction to the Thesis . 1 1.2 Significance of the Thesis . 5 2 REVIEW OF RELATED LITERATURE 9 2.1 Definition of Vitamin B12 and Food Sources . 9 2.2 Dietary Sources and Availability . 10 2.3 Requirements for the Daily Intake of Cobalamin in the Elderly . 11 2.4 Absorption, Storage and Excretion of Vitamin B12 ......... 12 2.4.1 Absorption and Storage . 12 2.4.2 Enterohepatic Circulation and Excretion of Vitamin B12 . 14 2.5 Functions of Vitamin B12 ....................... 15 2.6 Prevalence of Vitamin B12 Deficiency in the Elderly . 16 2.6.1 Factors Contributing to Poor Vitamin B12 Status with Ageing 16 I 2.6.2 Other Causes and Effects of Vitamin B12 Deficiency in the Elderly . 18 2.7 Clinical and Subclinical Manifestations of Vitamin B12 Deficiency in the Elderly . 19 2.7.1 Neurologic Effects of Vitamin B12 Deficiency . 19 2.7.2 Vitamin B12 and Cognitive Impairment . 20 2.7.3 Haematologic Effects of Deficiency . 21 2.7.4 Cardiovascular Effects of Deficiency . 22 2.7.5 Cognitive Impairment and the Function of the Neuromus- cular System . 23 2.8 Laboratory Diagnosis of Vitamin B Deficiency . 25 2.8.1 Indicators of Haematologic Status . 28 2.8.2 Serum or Plasma Cobalamin Levels . 28 2.8.3 Holotranscobalamin (HoloTC, Active B12)......... 28 2.8.4 Serum Methylmalonic Acid . 29 2.8.5 Serum Homocysteine Concentration . 29 2.9 Oral Supplements as Alternatives to Conventional Vitamin B12 Treatment............................... 29 3 HYPOTHESES AND OBJECTIVES 33 3.1 Hypotheses of Study I . 33 3.2 Objectives of Study I . 33 3.3 Hypotheses of Study II . 33 3.4 Objectives of Study II .
Load more

Recommended publications
  • Methionine Synthase Supports Tumor Tetrahydrofolate Pools
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Methionine synthase supports tumor tetrahydrofolate pools Joshua Z. Wang1,2,#, Jonathan M. Ghergurovich1,3,#, Lifeng Yang1,2, and Joshua D. Rabinowitz1,2,* 1 Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA 2 Department of Chemistry, Princeton University, Princeton, New Jersey, USA 3 Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA # These authors contributed equally to this work. *Corresponding author: Joshua Rabinowitz Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, Princeton University, Washington Rd, Princeton, NJ 08544, USA Phone: (609) 258-8985; e-mail: [email protected] Conflict of Interest Disclosure: J.D.R. is a paid advisor and stockholder in Kadmon Pharmaceuticals, L.E.A.F. Pharmaceuticals, and Rafael Pharmaceuticals; a paid consultant of Pfizer; a founder, director, and stockholder of Farber Partners and Serien Therapeutics. JDR and JMG are inventors of patents in the area of folate metabolism held by Princeton University. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Mammalian cells require activated folates to generate nucleotides for growth and division. The most abundant circulating folate species is 5-methyl tetrahydrofolate (5-methyl- THF), which is used to synthesize methionine from homocysteine via the cobalamin-dependent enzyme methionine synthase (MTR).
    [Show full text]
  • Environmental Health Criteria 124 Lindane
    Environmental Health Criteria 124 Lindane Please note that the layout and pagination of this web version are not identical with the printed version. Lindane (EHC 124, 1991) INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY ENVIRONMENTAL HEALTH CRITERIA 124 LINDANE This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the United Nations Environment Programme, the International Labour Organisation, or the World Health Organization. Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization First draft prepared by Dr M. Herbst, International Centre for the Study of Lindane, Lyon, France and Dr G.J. Van Esch, Bilthoven, The Netherlands World Health Orgnization Geneva, 1991 The International Programme on Chemical Safety (IPCS) is a joint venture of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization. The main objective of the IPCS is to carry out and disseminate evaluations of the effects of chemicals on human health and the quality of the environment. Supporting activities include the development of epidemiological, experimental laboratory, and risk-assessment methods that could produce internationally comparable results, and the development of manpower in the field of toxicology. Other activities carried out by the IPCS include the development of know-how for coping with chemical accidents,
    [Show full text]
  • The Vitamin B12 Coenzyme
    THE VITAMIN B12 COENZYME D. DoLPHIN, A. W. JoHNSON, R. RoDRIGO and N. SHAW Department of Chemistry, University of Nottingham, U.K. INTRODUCTION In 19•58 Barker and his associatesl-3 recognized a new coenzyme which controlled the conversion of glutamate into ß-methylaspartate by Clostridium tetanomorpkim. The coenzyme was shown4 to be related to !f;-vitamin B12, i.e. contair ing an adenine nucleotide grouping in place of the 5,6-dimethyl­ benziminawle nucleotide of vitamin B12, although similar coenzymes con­ taining btnziminazole or 5,6-dimethylbenziminazole were produced by growing C. tetanomorphum in the presence of the a ppropriate base5. Other variations of the nucleotide base have been achieved using Propionibacterium arabinosum in the presence of other purines and benziminazoles6• The pres­ ence of;:he coenzymes in a wide variety of micro-organisms such as several species of Actinomycetes including Streptomyces olivaceus and S. griseus has been dem( mstrated by the glutamate isomerase assay7 or by isolation. I t appears thü Vitamin B12 and its analogues are always biosynthesized in the form of their coenzymes. Preliminary physical and chemical studies sug­ gested that in the 5,6-dimethylbenzirninazolyl cobamide coenzyme the cyanide gr )up of vitamin B12, cyanocobalamin, was replaced by an adenine nucleoside':, 5, 8 and the determination9 of the complete structure (I; R = 5'-de·)xyadenosyl) of the coenzyme by X-ray analysis revealed the existence c f an essentially covalent bond between the cobalt atom and the S'.. carbon üom of the additional 5'-deoxyadenosine group. The molecule Me CH 2• CO· NH2 In the vitamin 8 12 coenzyme R =5' - deoxyadenosyl = Me Me 539 D.
    [Show full text]
  • Vitamins Minerals Nutrients
    vitamins minerals nutrients Vitamin B12 (Cyanocobalamin) Snapshot Monograph Vitamin B12 Nutrient name(s): (Cyanocobalamin) Vitamin B12 Most Frequent Reported Uses: Cyanocobalamin • Homocysteine regulation Methylcobalamin • Neurological health, including Adenosylcobalamin (Cobamamide) diabetic neuropathy, cognitive Hydroxycobalamin (European) function, vascular dementia, stroke prevention • Anemias, including pernicious and megaloblastic • Sulfite sensitivity Cyanocobalamin Introduction: Vitamin B12 was isolated from liver extract in 1948 and reported to control pernicious anemia. Cobalamin is the generic name of vitamin B12 because it contains the heavy metal cobalt, which gives this water-soluble vitamin its red color. Vitamin B12 is an essential growth factor and plays a role in the metabolism of cells, especially those of the gastrointestinal tract, bone marrow, and nervous tissue. Several different cobalamin compounds exhibit vitamin B12 activity. The most stable form is cyanocobalamin, which contains a cyanide group that is well below toxic levels. To become active in the body, cyanocobalamin must be converted to either methylcobalamin or adenosylcobalamin. Adenosylcobalamin is the primary form of vitamin B12 in the liver. © Copyright 2013, Integrative Health Resources, LLC | www.metaboliccode.com A protein in gastric secretions called intrinsic factor binds to vitamin B12 and facilitates its absorption. Without intrinsic factor, only a small percentage of vitamin B12 is absorbed. Once absorbed, relatively large amounts of vitamin B12 can be stored in the liver. The body actually reabsorbs vitamin B12 in the intestines and returns much of it to the liver, allowing for very little to be excreted from the body. However, when there are problems in the intestines, such as the microflora being imbalanced resulting in gastrointestinal inflammation, then vitamin B12 deficiencies can occur.
    [Show full text]
  • The Potential Protective Role of Vitamin K in Diabetic Neuropathy
    VITAMINS The potential protective role of vitamin K in diabetic neuropathy DILIP MEHTA Viridis Biopharma 6/10 Jogani Industrial Complex ew cases of diabetes are symptomatic pain relief (3-5). V. N. Purav Marg, Chunabhatti increasing worldwide at a rapid Mumbai 400022, India The etiopathology of peripheral pace, with the total number of neuropathy is poorly understood and many [email protected] people with diabetes was projected factors, including dietary deficiencies, may www.viridisbiopharma.com Nto rise from 171 million in 2000 to 366 million contribute to the clinical manifestation of the in 2030 – an increase of nearly 200 million in condition. Deficiency of vitamin B12 (also only three decades. There are more cases of known as cobalamin), which results in a lack diabetes in women and urban populations, of a related compound, methylcobalamin, is with diabetes in developing countries projected manifested by megaloblastic anemia, and to double in the coming years (1). has been associated with significant Based on reports from the Centers for neurological pathology, especially peripheral Disease Control and Prevention, type 2 neuropathy (6-8). Vitamin B12 is also diabetes dult onset diabetes affects associated with the onset of diabetic approximately 9.3% of the general neuropathy. In patients with diabetic population in the United States in contrast to neuropathy, vitamin B12 deficiency may be 25.9% among those 65 years or older (2). aggravated by the use of antidiabetic agents Diabetes mellitus accounts for 90% of the such as metformin (9-11). Even short-term cases of diabetes patients (3,4). treatment with metformin causes a decrease The prevalence of type 2 diabetes in serum cobalamin, folic acid and an increases with age, higher then 25 body increase in homocysteine, which leads to mass index and the presence of the disease peripheral neuropathy in patients with in family history.
    [Show full text]
  • Potential Benefits of Methylcobalamin: a Review
    Open Access Austin Journal of Pharmacology and Therapeutics Review Article Potential Benefits of Methylcobalamin: A Review Gupta JK* and Qureshi Shaiba Sana Department of Pharmacology, GLA University Mathura, Abstract India Methylcobalamin is an active form of vitamin B12 that helps in synthesis *Corresponding author: Jeetendra Kumar Gupta, of methionine and S-adenosylmethionine. It is required for integrity of myelin, Department of Pharmacology, Institute of Pharmaceutical neuronal function, proper red blood cell formation and DNA synthesis. The largest Research, GLA University Mathura, India group of vitamin B12 deficiency is found in typical vegetarians all over the world, which can be alleviated with its analogue Methylcobalamin. It is a beneficial Received: August 17, 2015; Accepted: September 30, drug to most of the common disorders like cardiovascular disorders, diabetes, 2015; Published: October 08, 2015 anemia, hyperhomocysteinemia and degenerative disorders. Methylcobalamin helps in the synthesis of neuronal lipids, regeneration of axonal nerves and has neuroprotective activity, which promote neurons to function in proper way and thus improves Alzheimer disease, Parkinsonism, Dementia and neuropathic syndromes. It is an approved treatment for peripheral neuropathy. Keywords: Mecobalamin; Neuropathy; Anemia; Nootropic; Dietary supplement Abbreviations essential for cell growth and replication. Sometimes the liver cannot convert cyanocobalamin into adequate amount of methylcobalamin SAMe: S-Adenosyl Methionine; ERK: Extracellular Signal- needed for proper neuronal functioning. Through enhanced Regulated Kinases; PKB: Protein Kinase B; B-globulin: Beta Globulin; methylation, it exerts its nerve cell protective effect and accelerates ENFD: Epidermal Nerve Fiber Density; DPN: Diabetic Peripheral its growth. A lot of energy is required for cyanocobalamin to remove Neuropathy; NSAIDs: Non Steroidal Anti Inflammatory Drugs; THF: its cyanide and replaces it with methyl group [3].
    [Show full text]
  • Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion and Pharmacokinetics
    TESI DOCTORAL HUMAN PHARMACOLOGY OF AYAHUASCA JORDI RIBA Barcelona, 2003 Director de la Tesi: DR. MANEL JOSEP BARBANOJ RODRÍGUEZ A la Núria, el Marc i l’Emma. No pasaremos en silencio una de las cosas que á nuestro modo de ver llamará la atención... toman un bejuco llamado Ayahuasca (bejuco de muerto ó almas) del cual hacen un lijero cocimiento...esta bebida es narcótica, como debe suponerse, i á pocos momentos empieza a producir los mas raros fenómenos...Yo, por mí, sé decir que cuando he tomado el Ayahuasca he sentido rodeos de cabeza, luego un viaje aéreo en el que recuerdo percibia las prespectivas mas deliciosas, grandes ciudades, elevadas torres, hermosos parques i otros objetos bellísimos; luego me figuraba abandonado en un bosque i acometido de algunas fieras, de las que me defendia; en seguida tenia sensación fuerte de sueño del cual recordaba con dolor i pesadez de cabeza, i algunas veces mal estar general. Manuel Villavicencio Geografía de la República del Ecuador (1858) Das, was den Indianer den “Aya-huasca-Trank” lieben macht, sind, abgesehen von den Traumgesichten, die auf sein persönliches Glück Bezug habenden Bilder, die sein inneres Auge während des narkotischen Zustandes schaut. Louis Lewin Phantastica (1927) Agraïments La present tesi doctoral constitueix la fase final d’una idea nascuda ara fa gairebé nou anys. El fet que aquest treball sobre la farmacologia humana de l’ayahuasca hagi estat una realitat es deu fonamentalment al suport constant del seu director, el Manel Barbanoj. Voldria expressar-li la meva gratitud pel seu recolzament entusiàstic d’aquest projecte, molt allunyat, per la natura del fàrmac objecte d’estudi, dels que fins al moment s’havien dut a terme a l’Àrea d’Investigació Farmacològica de l’Hospital de Sant Pau.
    [Show full text]
  • Vitamin and Mineral Requirements in Human Nutrition
    P000i-00xx 3/12/05 8:54 PM Page i Vitamin and mineral requirements in human nutrition Second edition VITPR 3/12/05 16:50 Page ii WHO Library Cataloguing-in-Publication Data Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements (1998 : Bangkok, Thailand). Vitamin and mineral requirements in human nutrition : report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. 1.Vitamins — standards 2.Micronutrients — standards 3.Trace elements — standards 4.Deficiency diseases — diet therapy 5.Nutritional requirements I.Title. ISBN 92 4 154612 3 (LC/NLM Classification: QU 145) © World Health Organization and Food and Agriculture Organization of the United Nations 2004 All rights reserved. Publications of the World Health Organization can be obtained from Market- ing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permis- sion to reproduce or translate WHO publications — whether for sale or for noncommercial distri- bution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; e-mail: [email protected]), or to Chief, Publishing and Multimedia Service, Information Division, Food and Agriculture Organization of the United Nations, 00100 Rome, Italy. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Tabla Composición De Alimentos REIMPRESIÓN
    INSTITUTO DE NUTRICIÓN DE CENTRO AMÉRICA Y PANAMÁ (INCAP) ORGANIZACIÓN PANAMERICANA DE LA SALUD (OPS) INCAP INCAP http://www.incap.int Segunda Edición © Copyright 2006 Guatemala, Centroamérica Tercera reimpresión Febrero 2012 INSTITUTO DE NUTRICIÓN DE CENTRO AMÉRICA Y PANAMÁ (INCAP) ORGANIZACIÓN PANAMERICANA DE LA SALUD (OPS) INCAP Tercera reimpresión, 2012 ME/085.3 2007 INCAP. Tabla de Composición de Alimentos de Centroamérica./INCAP/ Menchú, MT (ed); Méndez, H. (ed). Guatemala: INCAP/OPS, 2007. 2ª. Edición. viii - 128 pp. I.S.B.N. 99922-880-2-7 1. ANÁLISIS DE LOS ALIMENTOS 2. ALIMENTOS 3. VALOR NUTRITIVO Responsables de la producción de esta edición: Revisión y actualización técnica Licda. María Teresa Menchú Lic. Humberto Méndez, INCAP Coordinación de la edición y publicación Licda. Norma Alfaro, INCAP Segunda Edición Segunda reimpresión, 2009. Tercera reimpresión, 2012. Impresión: Serviprensa, S.A. PBX: 2245 8888 Tabla de Composición de Alimentos de Centroamérica Contenido Presentación................................................................................................................... v Introducción ..................................................................................................................vii Parte I. Documentación A. Antecedentes .............................................................................................................3 B. Metodología aplicada .................................................................................................. 4 C. Presentación de la Tabla de Composición
    [Show full text]
  • The Efficacy and Safety of Intramuscular Injections Of
    Original Article Singapore Med J 2011; 52(12) : 868 The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial Chiu C K, Low T H, Tey Y S, Singh V A, Shong H K ABSTRACT both singly or in combination with other forms Introduction:Chronic, nonspecific low back of treatment. pain is a difficult ailment to treat and poses an economic burden in terms of medical Keywords: methylcobalamin, nonspecific low expenses and productivity loss. The aim of back pain, vitamin B12 this study was to determine the efficacy and Singapore Med J 2011; 52(12): 868-873 safety of intramuscular metylcobalamin in the treatment of chronic nonspecific low back INTRODUCTION pain. Low back pain (LBP) affects a substantial proportion of the population. Almost every person will encounter an Methods: This was a double-blinded, episode of back pain at some point in one’s life. Back randomised, controlled experimental study. pain does not discriminate based on gender, age, race or 60 patients were assigned to either the culture. It disables the working adult from performing his methylcobalamin group or the placebo group. duties and paralyses the society due to the cost incurred The former received intramuscular injections in terms of treatment and productivity loss. In 1988, a of 500 mcg parenteral methylcobalamin in 1 survey was conducted in a semirural area in Malaysia. Department of ml solution three times a week for two weeks, Orthopaedic A total of 2,594 individuals from a multi-racial (Malay, Surgery, and the placebo group received 1 ml normal Chinese, Indian) community were interviewed.
    [Show full text]
  • Vitamin and Mineral Safety 3Rd Edition (2013) Council for Responsible Nutrition (CRN)
    EXCERPTED FROM: Vitamin and Mineral Safety 3rd Edition (2013) Council for Responsible Nutrition (CRN) www.crnusa.org Vitamin B12 Introduction Vitamin B12 helps maintain the body’s nervous system and blood cells and supports the production of DNA. Vitamin B12 also helps prevents a type of anemia and has been termed the “anti-pernicious anemia dietary factor.” Vitamin B12 is also the only known physiologically important compound that contains cobalt, and therefore the various forms of vitamin B12 are known collectively as cobalamins. Vitamin B12 is a cofactor in two enzymes that are fundamental in facilitating growth in humans. In the methylcobalamin form, vitamin B12 is the direct cofactor for methionine synthetase, the enzyme that recycles homocysteine back to methionine. Here, vitamin B12 and folic acid have closely related roles in one-carbon metabolism. In the adenosylcobalamin form, vitamin B12 is the cofactor in methylmalonyl-coenzyme A mutase. Both reactions are involved in promoting the rapid growth and proliferation of bone marrow cells and ultimately red blood cells (Expert Group on Vitamins and Minerals [EVM] 2003). Vitamin B12 is essential for the function and maintenance of the central nervous system, and severe deficiency in persons with pernicious anemia produces the neurological disease of posterolateral spinal cord degeneration (Herbert and Das 1994). The direct cause of pernicious anemia, in fact, is vitamin B12 deficiency, but the underlying defect is the absence of an intrinsic factor produced by specific stomach cells and needed for intestinal absorption of vitamin B12. Without this intrinsic factor, absorption is greatly reduced or fails, and a severe and persistent deficiency develops that is not preventable by the usual dietary levels of vitamin B12.
    [Show full text]
  • Essential Trace Elements in Human Health: a Physician's View
    Margarita G. Skalnaya, Anatoly V. Skalny ESSENTIAL TRACE ELEMENTS IN HUMAN HEALTH: A PHYSICIAN'S VIEW Reviewers: Philippe Collery, M.D., Ph.D. Ivan V. Radysh, M.D., Ph.D., D.Sc. Tomsk Publishing House of Tomsk State University 2018 2 Essential trace elements in human health UDK 612:577.1 LBC 52.57 S66 Skalnaya Margarita G., Skalny Anatoly V. S66 Essential trace elements in human health: a physician's view. – Tomsk : Publishing House of Tomsk State University, 2018. – 224 p. ISBN 978-5-94621-683-8 Disturbances in trace element homeostasis may result in the development of pathologic states and diseases. The most characteristic patterns of a modern human being are deficiency of essential and excess of toxic trace elements. Such a deficiency frequently occurs due to insufficient trace element content in diets or increased requirements of an organism. All these changes of trace element homeostasis form an individual trace element portrait of a person. Consequently, impaired balance of every trace element should be analyzed in the view of other patterns of trace element portrait. Only personalized approach to diagnosis can meet these requirements and result in successful treatment. Effective management and timely diagnosis of trace element deficiency and toxicity may occur only in the case of adequate assessment of trace element status of every individual based on recent data on trace element metabolism. Therefore, the most recent basic data on participation of essential trace elements in physiological processes, metabolism, routes and volumes of entering to the body, relation to various diseases, medical applications with a special focus on iron (Fe), copper (Cu), manganese (Mn), zinc (Zn), selenium (Se), iodine (I), cobalt (Co), chromium, and molybdenum (Mo) are reviewed.
    [Show full text]